Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification

Dec 27, 2022

Hyderabad (Telangana) [India], December 27 (ANI/PRNewswire): Hetero, India's leading pharmaceutical company with the widest global reach, today announced the receipt of World Health Organization...